Mor Yong opens conditions for risk groups What kind of drug to treat COVID-19 BA.5 should be used?

Mor Yong opens conditions for risk groups What kind of drug to treat COVID-19 BA.5 should be used?

Omicron BA.5 is a serious epidemic. “Doctor Yong” emphasizes that besides vaccination Requires special care for high-risk groups along with recommending the use of each type of treatment When should I use it? “Nation Online” is compiled here. Covid BA.5, a subspecies of Omicron, has spread more recently. Prof. Dr. Yong Phuworawan or “Mor Yong”, head of the center specializes in clinical virology. Department of Pediatrics Faculty […]

Read more
FDA approves hydroxychloroquine new drug application to address COVID-19 related shortage

FDA approves hydroxychloroquine new drug application to address COVID-19 related shortage

The FDA has approved an abbreviated new drug application for hydroxychloroquine sulfate tablets to address ongoing shortages of the drug sparked by its still unproven potential as a COVID-19 treatment. The application, submitted by Accord Healthcare, was approved on April 7. The approved indications are uncomplicated malaria due to Plasmodium falciparum, P. malariae, P. ovale, and P. vivax; chronic discoid lupus erythematosus and systemic lupus erythematosus in adults; and acute and chronic rheumatoid arthritis in adults.

Read more
Hydroxychloroquine and its effectiveness against COVID-19 treatment

Hydroxychloroquine and its effectiveness against COVID-19 treatment

Some politicians and doctors are sparring over whether to use Hydroxychloroquine against the new coronavirus, with many scientists saying the evidence is too thin to recommend it now. The drug Hydroxychloroquine can help tame an overactive immune system. It’s been used since the 1940s to prevent and treat malaria, and to treat rheumatoid arthritis and lupus. It’s sold in generic form and under the brand name Plaquenil in the United States. Doctors also can prescribe it off label for other purposes, as many are doing now for COVID-19.

Read more
Taj Pharmaceuticals: Our commitment to clients in the spread of COVID-19

Taj Pharmaceuticals: Our commitment to clients in the spread of COVID-19

We Taj Pharmaceuticals are in the midst of challenging times, brought upon us due to the unimaginable spread of COVID-19. As we grapple with this difficult and ever evolving situation, we wanted to reach out to make sure that you are doing okay and in case you needed any help. It is hard to think of a business that is not impacted by this pandemic, the effects of which we will all continue to feel for a long time. Taj Pharmaceuticals Limited company information | Taj Pharmaceuticals Key Executives | Taj Pharmaceuticals overview | Taj Pharmaceuticals

Read more